Areas of Research
- Biological Aging, Genetic and Environmental factors in MS — studying factors that drive disease severity in multiple sclerosis and related diseases
- Biosensing in Neurology — leveraging modern technology and biosensors to enhance neurological assessments
- Visual System in Neuroimmunological Disease — identifying precise relationships between structural damage and functional outcomes
Our research group has partnered with a range of neurology specialists in order to investigate the longitudinal neurological impacts of COVID-19. Our NeuCOVID study aims to track neurological symptom and disease developments and changes over a 10-year period through neuropsychological metrics and detailed interviews.
We are currently accepting new participants. If you have been diangosed with COVID-19 and have experienced neurological symptoms (headaches, brain fog, anosmia, etc.) and would like to participate in our study, contact Annalise Miner.
Clinical Trial Program
With a commitment to bring new therapies to our patients, we run a clinical trials program for MS and related diseases. Contact us directly for up-to-date information on enrolling studies.
Pediatric Research Program
Our Neuroimmunology Research Group has partnered with Rady Children's Hospital, where Dr. Jennifer Graves runs a pediatric MS neurology clinic, to investigate MS and related diseases in children.
In the News
Age of Your Cells, Not Your Birthdate, May Predict Disability Progression in Multiple Sclerosis
Telomere Length Tied to MS Disability — Biological as well as chronological aging may contribute to disease progression
Biologic aging is associated with MS disability progression
Novel MS vital sign: multi-sensor captures upper and lower limb dysfunction
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With MS